Outlook Surgical

About Outlook Surgical

Outlook Surgical, founded in 2007 and headquartered in Vancouver, British Columbia, Canada, is a medical device company focused on advancing surgical visualization technology. In October 2025, its flagship product, the Inova 1 Towerless Endoscope System, received FDA 510(k) clearance. The Inova 1 combines the functions of rigid and flexible endoscopes in a single device, eliminating the need for bulky towers, external cameras, or light sources. Designed for head and neck procedures, it is adaptable to multiple specialties, including orthopedics, gastroenterology, urology, obstetrics and gynecology, and neurosurgery. Commercial launch is planned for early 2026.

Core Business and Product Pipeline

Outlook Surgical’s core business focuses on the development of hybrid endoscope systems. The Inova 1 Towerless Endoscope System bridges the gap between rigid and flexible endoscopes. Key features include hybrid rigid-flexible design, one-handed operation, HD imaging, a compact pocket-sized control box, universal adaptability with third-party devices, and integrated chip-in-the-tip LED lighting. A digital rotation ring allows surgeons to reorient the image, improving USAbility and efficiency. The system supports instruments such as coblation wands, balloon catheters, forceps, cautery devices, and ablation tools.

Market Position and Competitive Advantages

The Inova 1 system represents a breakthrough in surgical visualization by combining precision with maneuverability. Surgeons can perform procedures more efficiently, with improved outcomes, enhanced patient comfort, and lower costs. Early feedback describes the device as “intuitive,” “time-saving,” and “long overdue.” Demonstrations at international conferences have attracted significant interest from physicians, distributors, and healthcare organizations worldwide.

Recent Developments

In October 2025, Outlook Surgical received FDA 510(k) clearance for the Inova 1 Towerless Endoscope System. The first-generation system is set to launch in early 2026, with commercialization by year-end. Beyond operating rooms, the device is expected to expand into office-based surgeries, emergency and hospital procedures, urgent care, humanitarian missions, military operations, and even space exploration. The company is also developing next-generation devices to continue advancing surgical visualization.

Contact Information

• Dr. Willard S. Noyes: Co-Founder, Chief Innovation Officer, Board Member – Email: willard.noyes@outlooksurgical.com

• Samantha Surrey, M.S.E.: Co-Founder, Board Member – Email: ssurrey@surreycapitalaprtners.com